Remus Pharmaceuticals Limited
In PositoAI's records, Remus Pharmaceuticals Limited has had 7 dividends since 2021 (₹10.5 per share in total); 2 bonus issues since 2016. Latest dividend: ₹0.5 per share, ex-date 22 Sep 2026.
Records start: dividends 2021, bonus and rights issues 2016, splits and buybacks 2022, mergers and demergers 2025. Earlier actions are not shown.
Remus Pharmaceuticals Limited Dividend History#
| Ex-date | Dividend |
|---|---|
| 2026 | ₹0.5 per share |
| 22 Sep 2026 | ₹0.5 per share |
| 2025 | ₹1 per share (2 payments) |
| 18 Sep 2025 | ₹0.5 per share |
| 14 Nov 2025 | ₹0.5 per share |
| 2024 | ₹5 per share (2 payments) |
| 2 May 2024 | ₹4 per share |
| 19 Nov 2024 | ₹1 per share |
| 2023 | ₹4 per share (2 payments) |
| 15 Sep 2023 | ₹2 per share |
| 27 Oct 2023 | ₹2 per share |
Amounts are per share as declared, not adjusted for later bonus issues or splits.
Remus Pharmaceuticals Limited Bonus History#
| Ex-date | Details |
|---|---|
| 4 Jul 2025 | 1:1 (1 new share for every 1 held) |
| 6 Jun 2024 | 3:1 (3 new shares for every 1 held) |
Questions
Does Remus Pharmaceuticals Limited pay dividends?
Yes. In PositoAI's records (from 2021), Remus Pharmaceuticals Limited has paid 7 dividends, the latest ₹0.5 per share with ex-date 22 September 2026.
How much dividend did Remus Pharmaceuticals Limited pay in 2025?
₹1 per share in 2025, in 2 payments.
Has Remus Pharmaceuticals Limited issued bonus shares?
Yes, 2 times in PositoAI's records (from 2016); the latest was 1:1 (1 new share for every 1 held) with ex-date 4 July 2025.
What is an ex-date and a record date?
To receive a dividend, bonus or other benefit, you must own the shares before the ex-date. The record date is the day the company checks its list of shareholders.
Records: dividends from 2021, bonus issues and rights issues from 2016, splits and buybacks from 2022, mergers and demergers from 2025; new actions are added every day. Amounts are per share in rupees. To receive a dividend or bonus, shares must be held before the ex-date. Please confirm dates with the company's own announcement. PositoAI is for research and education only and is not investment advice.